ClinicalTrials.Veeva

Menu

Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients (Long-termAPP)

R

Regional University Hospital Center (CHRU)

Status

Enrolling

Conditions

SARS-CoV 2 Pneumonia

Treatments

Other: quality of life questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06080737
DR 230170 - Long-term APP

Details and patient eligibility

About

Long term follow up of patients included in a randomized controlled trial evaluating awake prone positioning among patients suffering SARS-CoV2 pneumonia (NCT04358939)

Full description

All patients included in the initial trial who survived and were not lost to follow up at 28 days will be invited for a telephone interview to collect data on long term quality of life.

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients included in the randomized meta-trial evaluating awake prone position versus control among COVID-19 patients on high-flow nasal oxygen therapy (Ehrmann 2021).
  • Patients alive at D28
  • No opposition to participate in the research which evaluates mortality and quality of life by telephone interview.

Exclusion criteria

  • Patients lost to follow-up after 28 days.
  • Withdrawal of consent from randomized meta-trial by patient
  • Vulnerable person: safeguard of justice, curatorship, or guardianship
  • Patients refusing to answer telephone questionnaire.

Trial design

300 participants in 2 patient groups

standard oxygen group
Description:
telephone interview comprising a quality of life questionnaire
Treatment:
Other: quality of life questionnaire
awake prone group
Description:
telephone interview comprising a quality of life questionnaire
Treatment:
Other: quality of life questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Timothée BREHIN; Stephan EHRMANN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems